Gary S. Balkema Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gary S. Balkema.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary S. Balkema. Gary S. Balkema is Director in BRADY CORP ($BRC) and Director in PLx Pharma Inc. ($DPRX).
Latest Insider Trading Transactions of Gary S. Balkema
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2021 | BRC | BRADY CORP | Balkema Gary S. | Director | Option Exercise | M | 27.00 | 4,250 | 114,750 | 0 | |
Feb 23 2021 | BRC | BRADY CORP | Balkema Gary S. | Director | Payment of Exercise | F | 50.64 | 2,266 | 114,750 | 13,298 | 15.6 K to 13.3 K (-14.56 %) |
Feb 23 2021 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | M | 27.00 | 4,250 | 114,750 | 15,564 | 11.3 K to 15.6 K (+37.56 %) |
Nov 20 2020 | PLXP | PLx Pharma Inc. | Balkema Gary S. | Director | Option Exercise | A | 5.15 | 40,000 | 206,000 | 40,000 | |
Oct 01 2020 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 39.92 | 2,731 | 109,022 | 22,835 | 20.1 K to 22.8 K (+13.58 %) |
Mar 24 2020 | PLXP | PLx Pharma Inc. | Balkema Gary S. | Director | Option Exercise | A | 2.16 | 20,000 | 43,200 | 20,000 | |
Sep 24 2019 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 54.05 | 2,017 | 109,019 | 19,758 | 17.7 K to 19.8 K (+11.37 %) |
Mar 18 2019 | PLXP | PLx Pharma Inc. | Balkema Gary S. | Director | Option Exercise | A | 5.79 | 20,000 | 115,800 | 20,000 | |
Sep 26 2018 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 43.98 | 2,479 | 109,026 | 17,419 | 14.9 K to 17.4 K (+16.59 %) |
Sep 26 2017 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 36.85 | 2,579 | 95,036 | 14,615 | 12 K to 14.6 K (+21.43 %) |
Aug 17 2017 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 26.43 | 1,450 | 38,324 | 3,450 | 2 K to 3.5 K (+72.50 %) |
Apr 20 2017 | DPRX | PLx Pharma Inc. | Balkema Gary S. | Director | Option Exercise | A | 12.44 | 9,002 | 111,985 | 9,002 | |
Apr 20 2017 | DPRX | PLx Pharma Inc. | Balkema Gary S. | Director | Grant | A | 0.00 | 5,445 | 0 | 5,445 | 0 to 5.4 K |
Sep 27 2016 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 35.14 | 2,704 | 95,019 | 11,758 | 9.1 K to 11.8 K (+29.87 %) |
Sep 29 2015 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 19.96 | 4,159 | 83,014 | 8,770 | 4.6 K to 8.8 K (+90.20 %) |
Aug 04 2015 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 23.05 | 39 | 899 | 4,611 | 4.6 K to 4.6 K (+0.85 %) |
May 04 2015 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 26.93 | 34 | 916 | 4,572 | 4.5 K to 4.6 K (+0.75 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.49 | 100 | 2,749 | 2,000 | 1.9 K to 2 K (+5.26 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.49 | 100 | 2,749 | 1,900 | 1.8 K to 1.9 K (+5.56 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.49 | 100 | 2,749 | 1,800 | 1.7 K to 1.8 K (+5.88 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.49 | 100 | 2,749 | 1,700 | 1.6 K to 1.7 K (+6.25 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.53 | 100 | 2,753 | 1,600 | 1.5 K to 1.6 K (+6.67 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.55 | 90 | 2,480 | 1,500 | 1.4 K to 1.5 K (+6.38 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.54 | 100 | 2,754 | 1,410 | 1.3 K to 1.4 K (+7.63 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.54 | 210 | 5,783 | 1,310 | 1.1 K to 1.3 K (+19.09 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.53 | 600 | 16,518 | 1,100 | 500 to 1.1 K (+120.00 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.51 | 200 | 5,502 | 500 | 300 to 500 (+66.67 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.50 | 200 | 5,500 | 300 | 100 to 300 (+200.00 %) |
Feb 22 2011 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | P | 27.50 | 100 | 2,750 | 100 | 0 to 100 |
Aug 04 2010 | BRC | BRADY CORP | Balkema Gary S. | Director | Option Exercise | A | 28.35 | 10,000 | 283,500 | 10,000 |
Page: 1